WHO ICTRP trial
A multicenter, open-label, randomized study comparing INCB050465 to idelalisib…
EUCTR2017-001624-22-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2017-001624-22-ES |
|---|---|
| Public title | A multicenter, open-label, randomized study comparing INCB050465 to idelalisib in patients with relapsed or refractory follicular lymphoma |
| Scientific title | A Phase 2, Multicenter, Open-Label, Randomized Study Comparing INCB050465, a PI3Kd Inhibitor, to Idelalisib in Relapsed or Refractory Follicular Lymphoma - CITADEL-203 |
| Primary sponsor | Incyte Corporation |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United States;Spain;Israel;United Kingdom;Italy;Czech Republic;Hungary;Canada;Poland;Australia;Denmark;Germany;Sweden |
| Conditions | Follicular Lymphoma MedDRA version: 20.0 Level: LLT Classification code 10067070 Term: Follicular B-cell non-Hodgkin's lymphoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Product Code: INCB050465 1 mg tablet Pharmaceutical Form: Tablet INN or Proposed INN: not yet assigned Current Sponsor code: INCB050465 Other descriptive name: INCB050465 HYDROCHLORIDE Concentration unit: mg milligram(s) Concentration type… |
| Registration date | Jan 12, 2017 |
| Target size | 180 |
| Secondary IDs | INCB50465-203;NCT03126019;2017-001624-22-HU |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: